Synovial tissue inflammation in early and late osteoarthritis
By M. Benito, D. Veale, O. Fitzgerald, W. B. Berg, B. Bresnihan. Annals of the Rheumatic Diseases, 2005
1,023 citations recorded by the source corpus.
Subfields: Pathology and Forensic Medicine, Rheumatology
View Paper: https://www.semanticscholar.org/paper/7ccd11ed84c2f64a3d2a927aac8b9aca04738fc8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Rheumatology
- S. Goldring
- F. Berenbaum
- M. Goldring
- Richard F. Loeser
- J. Sokolove
- Christin M. Lepus
- Philip G. Conaghan
- A. Mathiessen
Citations in the corpus
- Cartilage homeostasis in health and rheumatic diseases (2009, neutral): “[30,31].”
- The Role of Synovitis in Osteoarthritis pathogenesis (2012, background): “The perivascular inflammatory cell infiltrates observed in the OA synovium are largely composed of lymphocyte populations [7].”
- Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations (2013, background): “Notably, the degree of infiltration is highly heterogeneous; some patients possess inflammation resembling that observed in RA, while others exhibit a minimally inflammatory and primarily degenerative histopathology [Benito et al. 2005].”
- The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis (2010, background): “Studies using ultrasonography and MRI have demonstrated synovitis in OA with relatively few symptoms or with limited alterations to the cartilage and subchondral bone, even in joints where synovitis was not detected clinically”
- Osteoarthritis: a disease of the joint as an organ. (2012, background): “Specific aspects of synovial inflammation, such as numbers of infiltrating macrophages, may be higher in early disease (71), but the prevalence of synovitis increases with advancing disease stage (72, 73).”
- Role of Antioxidants and Natural Products in Inflammation (2016, background): “Since many decades ago, there are also a diversity of clinical observations and molecular data for inflammation in osteoarthritis [26, 27].”
- Osteoarthritis: pathogenic signaling pathways and therapeutic targets (2023, background): “Low-grade synovial inflammation can be detected in >50% of OA patients at the early and late stages of the disease.(107,108) Therefore, among the synovial features, synovial inflammation has received the most attention from the OA research community.”